Tonghua Golden-Horse Pharmaceutical Industry CoLtd Third Quarter 2024 Earnings: EPS: CN¥0.012 (vs CN¥0.005 in 3Q 2023)

Simply Wall St · 10/21 22:11

Tonghua Golden-Horse Pharmaceutical Industry CoLtd (SZSE:000766) Third Quarter 2024 Results

Key Financial Results

  • Revenue: CN¥319.4m (up 1.2% from 3Q 2023).
  • Net income: CN¥11.5m (up 140% from 3Q 2023).
  • Profit margin: 3.6% (up from 1.5% in 3Q 2023).
  • EPS: CN¥0.012 (up from CN¥0.005 in 3Q 2023).
earnings-and-revenue-history
SZSE:000766 Earnings and Revenue History October 21st 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Tonghua Golden-Horse Pharmaceutical Industry CoLtd shares are up 1.6% from a week ago.

Risk Analysis

Be aware that Tonghua Golden-Horse Pharmaceutical Industry CoLtd is showing 1 warning sign in our investment analysis that you should know about...